Listed

West Pharmaceutical Services Inc

WSTNYSECIK 105770HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$874.5m, Q3 FY2026
Operating income$267.4m, Q3 FY2026
Net income$214.0m, Q3 FY2026
West Pharmaceutical Services Inc, income statement, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m732Revenue, Q4 FY2023, three months to 2023-12-31$732.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure695Revenue, Q1 FY2024, three months to 2024-03-31$695.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure702Revenue, Q2 FY2024, three months to 2024-06-30$702.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure747Revenue, Q3 FY2024, three months to 2024-09-30$746.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure749Revenue, Q4 FY2024, three months to 2024-12-31$748.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure698Revenue, Q1 FY2025, three months to 2025-03-31$698.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure767Revenue, Q2 FY2025, three months to 2025-06-30$766.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure805Revenue, Q3 FY2025, three months to 2025-09-30$804.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure805Revenue, Q4 FY2025, three months to 2025-12-31$805.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure845Revenue, Q1 FY2026, three months to 2026-03-31$844.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure872Revenue, Q2 FY2026, three months to 2026-06-30$872.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure875Revenue, Q3 FY2026, three months to 2026-09-30$874.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Cost of revenue$m454Cost of revenue, Q4 FY2023, three months to 2023-12-31$453.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure465Cost of revenue, Q1 FY2024, three months to 2024-03-31$465.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure472Cost of revenue, Q2 FY2024, three months to 2024-06-30$472.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure482Cost of revenue, Q3 FY2024, three months to 2024-09-30$482.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure475Cost of revenue, Q4 FY2024, three months to 2024-12-31$475.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure466Cost of revenue, Q1 FY2025, three months to 2025-03-31$466.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure493Cost of revenue, Q2 FY2025, three months to 2025-06-30$492.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure510Cost of revenue, Q3 FY2025, three months to 2025-09-30$510.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure501Cost of revenue, Q4 FY2025, three months to 2025-12-31$501.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure549Cost of revenue, Q1 FY2026, three months to 2026-03-31$548.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure543Cost of revenue, Q2 FY2026, three months to 2026-06-30$543.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure527Cost of revenue, Q3 FY2026, three months to 2026-09-30$527.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Gross profit$m278Gross profit, Q4 FY2023, three months to 2023-12-31$278.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure230Gross profit, Q1 FY2024, three months to 2024-03-31$230.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure230Gross profit, Q2 FY2024, three months to 2024-06-30$230.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure265Gross profit, Q3 FY2024, three months to 2024-09-30$264.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure274Gross profit, Q4 FY2024, three months to 2024-12-31$273.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure232Gross profit, Q1 FY2025, three months to 2025-03-31$231.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure274Gross profit, Q2 FY2025, three months to 2025-06-30$273.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure294Gross profit, Q3 FY2025, three months to 2025-09-30$294.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure304Gross profit, Q4 FY2025, three months to 2025-12-31$303.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure296Gross profit, Q1 FY2026, three months to 2026-03-31$296.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure329Gross profit, Q2 FY2026, three months to 2026-06-30$329.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure347Gross profit, Q3 FY2026, three months to 2026-09-30$347.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Research and development$m18.4Research and development, Q4 FY2023, three months to 2023-12-31$18.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure17.6Research and development, Q1 FY2024, three months to 2024-03-31$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure17.5Research and development, Q2 FY2024, three months to 2024-06-30$17.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure15.5Research and development, Q3 FY2024, three months to 2024-09-30$15.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure18.5Research and development, Q4 FY2024, three months to 2024-12-31$18.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure16.3Research and development, Q1 FY2025, three months to 2025-03-31$16.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure19.1Research and development, Q2 FY2025, three months to 2025-06-30$19.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure17.1Research and development, Q3 FY2025, three months to 2025-09-30$17.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure21.8Research and development, Q4 FY2025, three months to 2025-12-31$21.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure15.8Research and development, Q1 FY2026, three months to 2026-03-31$15.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure19.7Research and development, Q2 FY2026, three months to 2026-06-30$19.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure18.3Research and development, Q3 FY2026, three months to 2026-09-30$18.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Selling, general and administrative$m90.0Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$90.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure86.7Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$86.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure83.0Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$83.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure83.5Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$83.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure85.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$85.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure88.0Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$88.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure95.9Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$95.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure103Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$102.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure107Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$107.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure99.5Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$99.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure118Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$117.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure113Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$112.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Operating income$m161Operating income, Q4 FY2023, three months to 2023-12-31$160.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure123Operating income, Q1 FY2024, three months to 2024-03-31$122.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure126Operating income, Q2 FY2024, three months to 2024-06-30$126.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure161Operating income, Q3 FY2024, three months to 2024-09-30$161.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure160Operating income, Q4 FY2024, three months to 2024-12-31$159.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure107Operating income, Q1 FY2025, three months to 2025-03-31$107.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure154Operating income, Q2 FY2025, three months to 2025-06-30$153.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure168Operating income, Q3 FY2025, three months to 2025-09-30$167.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure157Operating income, Q4 FY2025, three months to 2025-12-31$156.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure177Operating income, Q1 FY2026, three months to 2026-03-31$177.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure179Operating income, Q2 FY2026, three months to 2026-06-30$179.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure267Operating income, Q3 FY2026, three months to 2026-09-30$267.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Interest expense$m1.2Interest expense, Q4 FY2023, three months to 2023-12-31$1.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-20, accession 0000105770-24-000015. Derived: 12-month figure less the 9-month figure.Report this figure1.6Interest expense, Q1 FY2024, three months to 2024-03-31$1.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure1.5Interest expense, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure0.7Interest expense, Q3 FY2024, three months to 2024-09-30$700.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure(0.8)Interest expense, Q4 FY2024, three months to 2024-12-31−$800.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure0.4Interest expense, Q1 FY2025, three months to 2025-03-31$400.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure0.1Interest expense, Q2 FY2025, three months to 2025-06-30$100.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure0.2Interest expense, Q3 FY2025, three months to 2025-09-30$200.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure(0.2)Interest expense, Q4 FY2025, three months to 2025-12-31−$200.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1.9Interest expense, Q1 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure2.6Interest expense, Q2 FY2026, three months to 2026-06-30$2.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure3.8Interest expense, Q3 FY2026, three months to 2026-09-30$3.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Income tax$m34.5Income tax, Q4 FY2023, three months to 2023-12-31$34.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure16.4Income tax, Q1 FY2024, three months to 2024-03-31$16.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure21.9Income tax, Q2 FY2024, three months to 2024-06-30$21.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure32.4Income tax, Q3 FY2024, three months to 2024-09-30$32.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure36.8Income tax, Q4 FY2024, three months to 2024-12-31$36.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure24.1Income tax, Q1 FY2025, three months to 2025-03-31$24.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure30.2Income tax, Q2 FY2025, three months to 2025-06-30$30.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure34.0Income tax, Q3 FY2025, three months to 2025-09-30$34.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure33.3Income tax, Q4 FY2025, three months to 2025-12-31$33.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure44.7Income tax, Q1 FY2026, three months to 2026-03-31$44.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure32.2Income tax, Q2 FY2026, three months to 2026-06-30$32.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure58.0Income tax, Q3 FY2026, three months to 2026-09-30$58.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Net income$m137Net income, Q4 FY2023, three months to 2023-12-31$137.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure115Net income, Q1 FY2024, three months to 2024-03-31$115.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure111Net income, Q2 FY2024, three months to 2024-06-30$111.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure136Net income, Q3 FY2024, three months to 2024-09-30$136.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure130Net income, Q4 FY2024, three months to 2024-12-31$130.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure89.8Net income, Q1 FY2025, three months to 2025-03-31$89.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure132Net income, Q2 FY2025, three months to 2025-06-30$131.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure140Net income, Q3 FY2025, three months to 2025-09-30$140.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure132Net income, Q4 FY2025, three months to 2025-12-31$132.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure139Net income, Q1 FY2026, three months to 2026-03-31$138.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure154Net income, Q2 FY2026, three months to 2026-06-30$154.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure214Net income, Q3 FY2026, three months to 2026-09-30$214.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Diluted EPS$ per sharenot reported1.55Diluted EPS, Q1 FY2024, three months to 2024-03-31$1.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure1.51Diluted EPS, Q2 FY2024, three months to 2024-06-30$1.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure1.85Diluted EPS, Q3 FY2024, three months to 2024-09-30$1.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figurenot reported1.23Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure1.82Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure1.92Diluted EPS, Q3 FY2025, three months to 2025-09-30$1.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figurenot reported1.92Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure2.15Diluted EPS, Q2 FY2026, three months to 2026-06-30$2.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure3.02Diluted EPS, Q3 FY2026, three months to 2026-09-30$3.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Basic EPS$ per sharenot reported1.57Basic EPS, Q1 FY2024, three months to 2024-03-31$1.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure1.52Basic EPS, Q2 FY2024, three months to 2024-06-30$1.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure1.87Basic EPS, Q3 FY2024, three months to 2024-09-30$1.87 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figurenot reported1.24Basic EPS, Q1 FY2025, three months to 2025-03-31$1.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure1.82Basic EPS, Q2 FY2025, three months to 2025-06-30$1.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure1.94Basic EPS, Q3 FY2025, three months to 2025-09-30$1.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figurenot reported1.93Basic EPS, Q1 FY2026, three months to 2026-03-31$1.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure2.17Basic EPS, Q2 FY2026, three months to 2026-06-30$2.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure3.04Basic EPS, Q3 FY2026, three months to 2026-09-30$3.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure

Balance sheet

Cash and equivalents$464.1m, Q3 FY2026
Long-term debt$202.9m, Q3 FY2026
Shareholders' equity$2.97bn, Q3 FY2026
West Pharmaceutical Services Inc, balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m854Cash and equivalents, FY2023, at 2023-12-31$853.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-18, accession 0000105770-25-000013.Report this figure602Cash and equivalents, Q1 FY2024, at 2024-03-31$601.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure446Cash and equivalents, Q2 FY2024, at 2024-06-30$446.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-25, accession 0000105770-24-000066.Report this figure491Cash and equivalents, Q3 FY2024, at 2024-09-30$490.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure485Cash and equivalents, FY2024, at 2024-12-31$484.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0000105770-26-000010.Report this figure404Cash and equivalents, Q1 FY2025, at 2025-03-31$404.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure510Cash and equivalents, Q2 FY2025, at 2025-06-30$509.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure629Cash and equivalents, Q3 FY2025, at 2025-09-30$628.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure791Cash and equivalents, FY2025, at 2025-12-31$791.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure521Cash and equivalents, Q1 FY2026, at 2026-03-31$521.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure436Cash and equivalents, Q2 FY2026, at 2026-06-30$435.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure464Cash and equivalents, Q3 FY2026, at 2026-09-30$464.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Current assets$m1,936Current assets, FY2023, at 2023-12-31$1.94bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-18, accession 0000105770-25-000013.Report this figure1,693Current assets, Q1 FY2024, at 2024-03-31$1.69bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure1,483Current assets, Q2 FY2024, at 2024-06-30$1.48bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-25, accession 0000105770-24-000066.Report this figure1,551Current assets, Q3 FY2024, at 2024-09-30$1.55bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure1,538Current assets, FY2024, at 2024-12-31$1.54bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-17, accession 0000105770-26-000010.Report this figure1,458Current assets, Q1 FY2025, at 2025-03-31$1.46bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure1,681Current assets, Q2 FY2025, at 2025-06-30$1.68bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure1,823Current assets, Q3 FY2025, at 2025-09-30$1.82bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure1,978Current assets, FY2025, at 2025-12-31$1.98bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure1,827Current assets, Q1 FY2026, at 2026-03-31$1.83bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure1,808Current assets, Q2 FY2026, at 2026-06-30$1.81bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure1,817Current assets, Q3 FY2026, at 2026-09-30$1.82bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Total assets$m3,830Total assets, FY2023, at 2023-12-31$3.83bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-18, accession 0000105770-25-000013.Report this figure3,602Total assets, Q1 FY2024, at 2024-03-31$3.60bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure3,489Total assets, Q2 FY2024, at 2024-06-30$3.49bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-25, accession 0000105770-24-000066.Report this figure3,675Total assets, Q3 FY2024, at 2024-09-30$3.68bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure3,643Total assets, FY2024, at 2024-12-31$3.64bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-17, accession 0000105770-26-000010.Report this figure3,618Total assets, Q1 FY2025, at 2025-03-31$3.62bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure3,953Total assets, Q2 FY2025, at 2025-06-30$3.95bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure4,106Total assets, Q3 FY2025, at 2025-09-30$4.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure4,270Total assets, FY2025, at 2025-12-31$4.27bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure4,110Total assets, Q1 FY2026, at 2026-03-31$4.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure4,076Total assets, Q2 FY2026, at 2026-06-30$4.08bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure4,061Total assets, Q3 FY2026, at 2026-09-30$4.06bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Current liabilities$m672Current liabilities, FY2023, at 2023-12-31$671.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-18, accession 0000105770-25-000013.Report this figure648Current liabilities, Q1 FY2024, at 2024-03-31$648.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure634Current liabilities, Q2 FY2024, at 2024-06-30$633.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-25, accession 0000105770-24-000066.Report this figure517Current liabilities, Q3 FY2024, at 2024-09-30$516.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure550Current liabilities, FY2024, at 2024-12-31$550.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-17, accession 0000105770-26-000010.Report this figure527Current liabilities, Q1 FY2025, at 2025-03-31$526.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure605Current liabilities, Q2 FY2025, at 2025-06-30$604.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure635Current liabilities, Q3 FY2025, at 2025-09-30$635.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure655Current liabilities, FY2025, at 2025-12-31$654.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure674Current liabilities, Q1 FY2026, at 2026-03-31$674.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure641Current liabilities, Q2 FY2026, at 2026-06-30$640.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure644Current liabilities, Q3 FY2026, at 2026-09-30$644.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Total liabilities$m949Total liabilities, FY2023, at 2023-12-31$948.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-18, accession 0000105770-25-000013.Report this figure922Total liabilities, Q1 FY2024, at 2024-03-31$921.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure913Total liabilities, Q2 FY2024, at 2024-06-30$912.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-25, accession 0000105770-24-000066.Report this figure923Total liabilities, Q3 FY2024, at 2024-09-30$923.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure961Total liabilities, FY2024, at 2024-12-31$961.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-17, accession 0000105770-26-000010.Report this figure935Total liabilities, Q1 FY2025, at 2025-03-31$935.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure1,024Total liabilities, Q2 FY2025, at 2025-06-30$1.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure1,054Total liabilities, Q3 FY2025, at 2025-09-30$1.05bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure1,094Total liabilities, FY2025, at 2025-12-31$1.09bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure1,119Total liabilities, Q1 FY2026, at 2026-03-31$1.12bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure1,086Total liabilities, Q2 FY2026, at 2026-06-30$1.09bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure1,093Total liabilities, Q3 FY2026, at 2026-09-30$1.09bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Long-term debt$m72.8Long-term debt, FY2023, at 2023-12-31$72.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-18, accession 0000105770-25-000013.Report this figure72.8Long-term debt, Q1 FY2024, at 2024-03-31$72.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure72.9Long-term debt, Q2 FY2024, at 2024-06-30$72.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-07-25, accession 0000105770-24-000066.Report this figure203Long-term debt, Q3 FY2024, at 2024-09-30$202.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure203Long-term debt, FY2024, at 2024-12-31$202.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-17, accession 0000105770-26-000010.Report this figure203Long-term debt, Q1 FY2025, at 2025-03-31$202.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure203Long-term debt, Q2 FY2025, at 2025-06-30$202.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure203Long-term debt, Q3 FY2025, at 2025-09-30$202.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure203Long-term debt, FY2025, at 2025-12-31$202.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure203Long-term debt, Q1 FY2026, at 2026-03-31$202.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure203Long-term debt, Q2 FY2026, at 2026-06-30$202.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure203Long-term debt, Q3 FY2026, at 2026-09-30$202.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Current portion of debt$m134Current portion of debt, FY2023, at 2023-12-31$134.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-18, accession 0000105770-25-000013.Report this figure133Current portion of debt, Q1 FY2024, at 2024-03-31$133.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure133Current portion of debt, Q2 FY2024, at 2024-06-30$132.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-07-25, accession 0000105770-24-000066.Report this figure0.0Current portion of debt, Q3 FY2024, at 2024-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-17, accession 0000105770-26-000010.Report this figure0.0Current portion of debt, Q1 FY2025, at 2025-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure0.0Current portion of debt, Q2 FY2025, at 2025-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure0.0Current portion of debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure0.0Current portion of debt, Q1 FY2026, at 2026-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure0.0Current portion of debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure0.0Current portion of debt, Q3 FY2026, at 2026-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure
Shareholders' equity$m2,881Shareholders' equity, FY2023, at 2023-12-31$2.88bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-17, accession 0000105770-26-000010.Report this figure2,681Shareholders' equity, Q1 FY2024, at 2024-03-31$2.68bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure2,577Shareholders' equity, Q2 FY2024, at 2024-06-30$2.58bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure2,752Shareholders' equity, Q3 FY2024, at 2024-09-30$2.75bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure2,682Shareholders' equity, FY2024, at 2024-12-31$2.68bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure2,683Shareholders' equity, Q1 FY2025, at 2025-03-31$2.68bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure2,929Shareholders' equity, Q2 FY2025, at 2025-06-30$2.93bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure3,052Shareholders' equity, Q3 FY2025, at 2025-09-30$3.05bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure3,176Shareholders' equity, FY2025, at 2025-12-31$3.18bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure2,990Shareholders' equity, Q1 FY2026, at 2026-03-31$2.99bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure2,990Shareholders' equity, Q2 FY2026, at 2026-06-30$2.99bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure2,968Shareholders' equity, Q3 FY2026, at 2026-09-30$2.97bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure

Cash flow

Operating cash flow$189.5m, Q3 FY2026
Capital expenditure$39.1m, Q3 FY2026
Share repurchases$231.0m, Q3 FY2026
West Pharmaceutical Services Inc, cash flow, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m239Operating cash flow, Q4 FY2023, three months to 2023-12-31$239.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure118Operating cash flow, Q1 FY2024, three months to 2024-03-31$118.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure165Operating cash flow, Q2 FY2024, three months to 2024-06-30$165.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-24, accession 0000105770-25-000065. Derived: 6-month figure less the 3-month figure.Report this figure180Operating cash flow, Q3 FY2024, three months to 2024-09-30$180.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-23, accession 0000105770-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure190Operating cash flow, Q4 FY2024, three months to 2024-12-31$190.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure129Operating cash flow, Q1 FY2025, three months to 2025-03-31$129.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure177Operating cash flow, Q2 FY2025, three months to 2025-06-30$177.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-23, accession 0000105770-26-000099. Derived: 6-month figure less the 3-month figure.Report this figure197Operating cash flow, Q3 FY2025, three months to 2025-09-30$197.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0000105770-26-000121. Derived: 9-month figure less the 6-month figure.Report this figure251Operating cash flow, Q4 FY2025, three months to 2025-12-31$251.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure89.9Operating cash flow, Q1 FY2026, three months to 2026-03-31$89.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure124Operating cash flow, Q2 FY2026, three months to 2026-06-30$124.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-23, accession 0000105770-26-000099. Derived: 6-month figure less the 3-month figure.Report this figure190Operating cash flow, Q3 FY2026, three months to 2026-09-30$189.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0000105770-26-000121. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m109Capital expenditure, Q4 FY2023, three months to 2023-12-31$108.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure90.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$90.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure100Capital expenditure, Q2 FY2024, three months to 2024-06-30$100.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-24, accession 0000105770-25-000065. Derived: 6-month figure less the 3-month figure.Report this figure81.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$81.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-23, accession 0000105770-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure105Capital expenditure, Q4 FY2024, three months to 2024-12-31$104.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure71.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$71.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure75.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$75.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-23, accession 0000105770-26-000099. Derived: 6-month figure less the 3-month figure.Report this figure63.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$63.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0000105770-26-000121. Derived: 9-month figure less the 6-month figure.Report this figure76.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$76.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure42.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$42.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure43.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$43.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-23, accession 0000105770-26-000099. Derived: 6-month figure less the 3-month figure.Report this figure39.1Capital expenditure, Q3 FY2026, three months to 2026-09-30$39.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0000105770-26-000121. Derived: 9-month figure less the 6-month figure.Report this figure
Dividends paid$m14.8Dividends paid, Q4 FY2023, three months to 2023-12-31$14.8m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure14.7Dividends paid, Q1 FY2024, three months to 2024-03-31$14.7m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure14.6Dividends paid, Q2 FY2024, three months to 2024-06-30$14.6m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-07-24, accession 0000105770-25-000065. Derived: 6-month figure less the 3-month figure.Report this figure14.5Dividends paid, Q3 FY2024, three months to 2024-09-30$14.5m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-10-23, accession 0000105770-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure15.3Dividends paid, Q4 FY2024, three months to 2024-12-31$15.3m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure15.2Dividends paid, Q1 FY2025, three months to 2025-03-31$15.2m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure15.1Dividends paid, Q2 FY2025, three months to 2025-06-30$15.1m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-07-23, accession 0000105770-26-000099. Derived: 6-month figure less the 3-month figure.Report this figure15.1Dividends paid, Q3 FY2025, three months to 2025-09-30$15.1m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-10-29, accession 0000105770-26-000121. Derived: 9-month figure less the 6-month figure.Report this figure15.8Dividends paid, Q4 FY2025, three months to 2025-12-31$15.8m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure15.8Dividends paid, Q1 FY2026, three months to 2026-03-31$15.8m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure15.7Dividends paid, Q2 FY2026, three months to 2026-06-30$15.7m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-07-23, accession 0000105770-26-000099. Derived: 6-month figure less the 3-month figure.Report this figure15.5Dividends paid, Q3 FY2026, three months to 2026-09-30$15.5m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-10-29, accession 0000105770-26-000121. Derived: 9-month figure less the 6-month figure.Report this figure
Share repurchases$m177Share repurchases, Q4 FY2023, three months to 2023-12-31$177.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure267Share repurchases, Q1 FY2024, three months to 2024-03-31$267.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure187Share repurchases, Q2 FY2024, three months to 2024-06-30$187.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-24, accession 0000105770-25-000065. Derived: 6-month figure less the 3-month figure.Report this figure52.4Share repurchases, Q3 FY2024, three months to 2024-09-30$52.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-23, accession 0000105770-25-000093. Derived: 9-month figure less the 6-month figure.Report this figure54.4Share repurchases, Q4 FY2024, three months to 2024-12-31$54.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure134Share repurchases, Q1 FY2025, three months to 2025-03-31$133.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure0.5Share repurchases, Q2 FY2025, three months to 2025-06-30$500.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-23, accession 0000105770-26-000099. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-29, accession 0000105770-26-000121. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-17, accession 0000105770-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure298Share repurchases, Q1 FY2026, three months to 2026-03-31$297.6m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure157Share repurchases, Q2 FY2026, three months to 2026-06-30$156.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-23, accession 0000105770-26-000099. Derived: 6-month figure less the 3-month figure.Report this figure231Share repurchases, Q3 FY2026, three months to 2026-09-30$231.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-10-29, accession 0000105770-26-000121. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)70.80m, Q3 FY2026
West Pharmaceutical Services Inc, shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares75.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3175,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-25, accession 0000105770-24-000031.Report this figure75.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3075,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-25, accession 0000105770-24-000066.Report this figure75.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3075,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-24, accession 0000105770-24-000081.Report this figure74.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3174,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-24, accession 0000105770-25-000036.Report this figure73.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3073,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-24, accession 0000105770-25-000065.Report this figure73.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3073,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-23, accession 0000105770-25-000093.Report this figure73.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3173,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure72.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3072,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure72.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3072,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure72.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3172,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-23, accession 0000105770-26-000049.Report this figure71.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3071,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-23, accession 0000105770-26-000099.Report this figure70.8Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3070,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure

Shares outstanding: 69.66mShares outstanding, period not labelled, at 2026-10-2169,661,036 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-29, accession 0000105770-26-000121.Report this figure at Oct 21, 2026, from the cover of the 10-Q filed Oct 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:13 ET. Listed shows no prices and gives no investment advice.